Form 4: Director Gary Roubin Increases Stake in InspireMD
Statement of Changes in Beneficial Ownership
Director Gary S. Roubin acquired 90,000 shares of InspireMD, Inc. common stock at a weighted average price of $1.18.
Summary
- Director Gary S. Roubin purchased 90,000 shares of InspireMD, Inc. (NSPR) common stock.
- The transaction occurred on May 7, 2026.
- The shares were acquired at a weighted average price of $1.18 per share, with individual transaction prices ranging from $1.15 to $1.20.
- Following this transaction, the reporting person's total beneficial ownership stands at 834,478 shares.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying often indicates confidence in the company's long-term strategic direction.
Positives
- Insider confidence is demonstrated by a director increasing their equity position in the company.
- The purchase of 90,000 shares represents a meaningful commitment of capital by a member of the board.
Negatives
- None identified in this filing.
Risks
- Market price volatility for NSPR shares.
- General risks associated with the medical device industry and regulatory environment.
Future Outlook
Not applicable as this is a Form 4 insider transaction filing.
Industry Context
StockSavvy.ai notes that insider buying is generally viewed as a positive signal by the market, suggesting that those with the most intimate knowledge of the company's operations and prospects believe the stock is undervalued.
Comparison to Industry Standards
- Insider purchases are standard practice for directors seeking to align their interests with shareholders.
- The volume of the purchase is consistent with typical director-level equity accumulation in small-cap medical device firms.
Stakeholder Impact
- Shareholders may perceive this as a vote of confidence in the company's current valuation and future prospects.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/07/2026 | Date of the reported stock purchase transaction. |
| 05/08/2026 | Date of filing and signature by the Attorney-in-Fact. |
Keywords
InspireMD, NSPR, Insider Trading, Form 4, Gary Roubin, Director Purchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.